Wells Fargo & Company ARRIVENT BIOPHARMA INC Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Number of Shares
3,603
Previous 3,231
11.51%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%